Ministry of Health Issues Directive as Infant Vaccine Shortage Hits Kenya

The Ministry of Health has issued a directive following a temporary shortage of the Rotavac Frozen rotavirus vaccine, routinely given to infants at 6, 10, and 14 weeks.

In a statement dated Friday, March 6, 2026, the Ministry said Gavi, the Vaccine Alliance, informed Kenya that the manufacturer, Bharat Biotech, is experiencing production delays due to facility upgrades. This disruption is expected to affect vaccine deliveries throughout 2026 and into 2027.

“The Ministry of Health would like to inform the public of a temporary disruption in the global supply of the Rotavac Frozen rotavirus vaccine, routinely administered to infants at 6, 10, and 14 weeks of age,” read part of the statement.

Ministry of Health Warns of Rotavirus Vaccine Stock Shortage

According to the Ministry, as of March 3, 2026, Kenya had only 4,000 doses at the national level, less than one month’s stock.

A shipment initially expected in January has been delayed, with the earliest anticipated arrival now scheduled for the end of April.

Also Read: Win for Kenya as Ministry Launches Long-Acting HIV Prevention Injection

The Ministry said it is working closely with UNICEF and other partners to fast-track shipments, redistribute available doses fairly across counties, and monitor stock levels to minimize disruption to routine immunisation services.

Parents and caregivers are urged to continue attending immunisation appointments and to strengthen diarrhoea prevention measures, including handwashing with soap, safe water treatment, proper food handling, and maintaining clean household environments.

“Protecting the health of all children remains our highest priority,” said Cabinet Secretary Aden Duale.

At the same time, the Ministry pledged to provide regular updates as it works with global partners to restore normal vaccine supply.

About the Vaccine

The Rotavac Frozen rotavirus vaccine is used to protect infants against rotavirus, a highly contagious virus that can cause severe diarrhoea and dehydration in young children. In Kenya, the vaccine is administered at six, ten, and fourteen weeks as part of the routine immunisation schedule.

Also Read: Kenya Targets Local Vaccine Production by 2027

Produced by Bharat Biotech in India, Rotavac Frozen is supported globally by Gavi, the Vaccine Alliance, which helps ensure countries like Kenya have access to the life-saving vaccine. The vaccine must be stored frozen to remain effective.

Rotavac Frozen plays a critical role in preventing severe diarrhoeal illness, hospitalisations, and deaths among children under five. By including it in the national immunisation program, Kenya aims to give every child a chance at protection against this common but potentially deadly disease.

Follow our WhatsApp channel for instant news updates

Health CS Aden Duale at past event. PHOTO/MoH